SARCOMAS
Clinical trials for SARCOMAS explained in plain language.
Never miss a new study
Get alerted when new SARCOMAS trials appear
Sign up with your email to follow new studies for SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug ZL-6201 enters early human testing
Disease control Recruiting nowThis early-stage study tests a new drug called ZL-6201 in adults with sarcoma or certain solid tumors that have spread or cannot be removed by surgery. The main goal is to check the drug's safety and find the right dose. About 180 people will take part in this study.
Matched conditions: SARCOMAS
Phase: PHASE1 • Sponsor: Zai Lab (Shanghai) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug combo targets tough sarcomas in kids and adults
Disease control Recruiting nowThis early-phase trial tests the safety and best dose of cabozantinib combined with high-dose ifosfamide in 30 children and adults with sarcomas (like Ewing sarcoma or osteosarcoma) that have returned or not responded to standard chemotherapy. The goal is to find a dose that cont…
Matched conditions: SARCOMAS
Phase: PHASE1 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New pain cocktail could ease suffering after cancer amputation
Symptom relief Recruiting nowThis study compares two spinal anesthesia recipes for people having a leg amputated above the knee due to sarcoma (a type of cancer). One group gets the standard fentanyl plus bupivacaine, the other gets an added drug called dexmedetomidine. The goal is to see if the combo delays…
Matched conditions: SARCOMAS
Phase: NA • Sponsor: National Cancer Institute, Egypt • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC